Connor, Clark & Lunn Investment Management Ltd. Assembly Biosciences, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

  • $18.8 Billion
  • Q3 2024

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$1.09 - $20.4 $70,151 - $1.31 Million
-64,359 Reduced 49.6%
65,393 $85,000
Q3 2022

Nov 10, 2022
SELL
$1.7 - $20.52 $22,377 - $270,104
-13,163 Reduced 9.21%
129,752 $213,000
Q2 2022

Aug 05, 2022
SELL
$1.35 - $2.29 $29,747 - $50,460
-22,035 Reduced 13.36%
142,915 $300,000
Q1 2022

May 12, 2022
SELL
$1.46 - $2.45 $7,688 - $12,901
-5,266 Reduced 3.09%
164,950 $340,000
Q4 2021

Feb 10, 2022
BUY
$2.13 - $3.46 $29,396 - $47,751
13,801 Added 8.82%
170,216 $397,000
Q3 2021

Nov 12, 2021
BUY
$3.14 - $3.9 $14,877 - $18,478
4,738 Added 3.12%
156,415 $544,000
Q2 2021

Aug 12, 2021
BUY
$3.8 - $4.56 $49,141 - $58,969
12,932 Added 9.32%
151,677 $589,000
Q1 2021

May 13, 2021
BUY
$4.33 - $6.63 $600,765 - $919,879
138,745 New
138,745 $638,000
Q2 2020

Aug 13, 2020
SELL
$14.57 - $23.96 $233,076 - $383,288
-15,997 Closed
0 $0
Q1 2020

May 13, 2020
BUY
$10.27 - $21.23 $164,289 - $339,616
15,997 New
15,997 $237,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $737M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email